Condition : Rheumatoid Arthritis Intervention : Drug: tocilizumab [RoActemra/Actemra] Sponsor : Hoffmann-La Roche Recruiting - verified July 2011

Condition : Psoriatic Arthritis Interventions : Drug: Apremilast 20mg; Drug: Apremilast 30mg; Drug: Placebo + 20 mg Apremilast; Drug: Placebo + 30 mg Apremilast Sponsors : Celgene Corporation; Celgene...

Condition : Psoriatic Arthritis Interventions : Drug: Apremilast 20mg; Drug: Apremilast 30mg; Drug: Placebo + 20 mg Apremilast; Drug: Placebo + 30 mg Apremilast Sponsors : Celgene Corporation; Celgene...

Condition : Arthritis, Rheumatoid Intervention : Sponsor : Biogen Idec Active, not recruiting - verified August 2011

Condition : Arthritis, Rheumatoid Interventions : Drug: Etoricoxib 60 mg; Drug: Etoricoxib 90 mg; Drug: Placebo to Etoricoxib 60 mg; Drug: Placebo to Etoricoxib 90 mg Sponsor : Merck Recruiting - veri...

The objective of the study is to investigate the safety and tolerability of BI 113823 in male and female patients with osteoarthritis, following oral administration of BI 113823 with repeated rising d...

Condition : Spondylitis, Ankylosing Interventions : Drug: Part I - etoricoxib 60 mg; Drug: Part I - etoricoxib 90 mg; Drug: Part I- naproxen 1000 mg; Drug: Part I - Placebo to naproxen 500 mg; Drug: P...

Condition : Arthritis, Rheumatoid Interventions : Drug: Etoricoxib 60 mg; Drug: Etoricoxib 90 mg; Drug: Placebo to Etoricoxib 60 mg; Drug: Placebo to Etoricoxib 90 mg Sponsors : Merck; Merck Recruitin...

Condition : Arthritis, Rheumatoid Interventions : Drug: Part 1: Etoricoxib 60 mg; Drug: Part 1: Etoricoxib 90 mg; Drug: Part 2: Etoricoxib 60 mg; Drug: Part 2: Etoricoxib 90 mg; Drug: Part 1: Placebo...

Condition : Spondylitis, Ankylosing Interventions : Drug: Part I - etoricoxib 60 mg; Drug: Part I - etoricoxib 90 mg; Drug: Part I- naproxen 1000 mg; Drug: Part I - Placebo to etoricoxib 60 mg; Drug:...